person · Reporting owner

O'Meara Maeve

Disclosed activity across 2 companies

Tapewire entity: 95778
SEC CIK: 0001742487

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Starling Oncology, Inc.TOI · Entity 5327	Director	December 26, 2023	December 28, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Starling Oncology, Inc.

Report date December 26, 2023 · Filed December 28, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common stockSEC Table I · non-derivative	Direct	109,104	Reported balance After 2023-12-26 transaction · row 1 1 source row Row 1 · 2023-12-26 · Grant · Acquired 50,000 · Balance 109,104 F1: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

CASTLIGHT HEALTH, INC.

Report date January 12, 2022 · Filed February 18, 2022

Section 16 reporting ended · disclosed 2022-02-18. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2022-02-17 transaction · row 1 1 source row Row 1 · 2022-02-17 · Disposition to issuer · Disposed 1,625,989 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger (the "Surviving Corporation"), as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	397,500	Reported balance After 2022-01-12 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-01-12 · Grant · Acquired 397,500 · Balance 397,500 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-02-17 · Disposition to issuer · Disposed 12,500 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F4: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2022-02-17 · Disposition to issuer · Disposed 25,000 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F6: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-02-17 · Disposition to issuer · Disposed 115,313 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F7: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2022-02-17 · Disposition to issuer · Disposed 301,725 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F8: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-02-17 · Disposition to issuer · Disposed 558,000 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F9: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-02-17 · Disposition to issuer · Disposed 430,625 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F10: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-02-17 · Disposition to issuer · Disposed 397,500 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.09 · Expires 2022-11-07	Direct	0	Reported balance After 2022-02-17 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-02-17 · Disposition to issuer · Disposed 9,000 · Balance 0 F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.12 · Expires 2023-02-11	Direct	0	Reported balance After 2022-02-17 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2022-02-17 · Disposition to issuer · Disposed 7,500 · Balance 0 F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.35 · Expires 2023-10-24	Direct	0	Reported balance After 2022-02-17 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2022-02-17 · Disposition to issuer · Disposed 20,000 · Balance 0 F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.99 · Expires 2026-02-23	Direct	0	Reported balance After 2022-02-17 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2022-02-17 · Disposition to issuer · Disposed 155,000 · Balance 0 F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F11: The stock option is fully vested and immediately exercisable.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2030-03-02	Direct	0	Reported balance After 2022-02-17 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2022-02-17 · Disposition to issuer · Disposed 331,000 · Balance 0 F17: Pursuant to the Merger Agreement, to the extent vested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. To the extent unvested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash replacement amount equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option cash equivalent award valued based on the excess of the Merger Consideration over the option exercise price (the "Option Consideration"). [continued in fn 18]. F18: [cont. from fn. 17] The payment of the Option Consideration will be subject to vesting in accordance with the vesting schedule applicable to the unvested portion of the option immediately prior to the Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F16: The option vested as to 1/5th of the total number of shares on March 3, 2021, and thereafter vests as to 1/36th monthly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger (the "Surviving Corporation"), as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time.

F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.

F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F4: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date.

F6: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F7: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F8: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F9: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F10: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F11: The stock option is fully vested and immediately exercisable.

F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date.

F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.

F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option.

F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time.

F16: The option vested as to 1/5th of the total number of shares on March 3, 2021, and thereafter vests as to 1/36th monthly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F17: Pursuant to the Merger Agreement, to the extent vested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. To the extent unvested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash replacement amount equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option cash equivalent award valued based on the excess of the Merger Consideration over the option exercise price (the "Option Consideration"). [continued in fn 18].

F18: [cont. from fn. 17] The payment of the Option Consideration will be subject to vesting in accordance with the vesting schedule applicable to the unvested portion of the option immediately prior to the Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	33,125	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,875 Underlying: Class B Common Stock · 33,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	62,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 682,000 Underlying: Class B Common Stock · 62,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	43,103	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,932 Underlying: Class B Common Stock · 43,103 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	23,062	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,438 Underlying: Class B Common Stock · 23,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · derivative · entry 9 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · derivative · entry 8 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	33,125	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · nonDerivative · entry 6 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,523,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	62,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · nonDerivative · entry 5 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	43,103	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · nonDerivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	23,062	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · nonDerivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,385,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 16, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,350,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 17, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	SaleClass B Common Stock	59,615	$1.89	$112,886.96	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · nonDerivative · entry 7 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,337,540 F1 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.76 to $2.025 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	62,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 744,000 Underlying: Class B Common Stock · 62,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	43,104	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,035 Underlying: Class B Common Stock · 43,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	23,063	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,500 Underlying: Class B Common Stock · 23,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · derivative · entry 9 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	3,125	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · derivative · entry 8 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 1/4th of the RSUs vested on March 7, 2018, and the remainder will vest 1/20th quarterly in 12 equal installments and then 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/4th of the RSUs vested on March 7, 2018, and the remainder will vest 1/20th quarterly in 12 equal installments and then 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	62,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · nonDerivative · entry 6 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	43,104	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · nonDerivative · entry 5 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,335,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	23,063	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · nonDerivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,292,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · nonDerivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,268,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,256,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 16, 2021 Filed Feb 18, 2021 17:07 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	3,125	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011938 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 10, 2021 Filed Feb 12, 2021 20:04 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	GrantRestricted Stock Units (RSU) · Derivative	530,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-010484 · doc4.xml · derivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,000 Underlying: Class B Common Stock · 530,000 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 1/16th of the RSUs will vest on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F2 · derivative.expiration_date: 1/16th of the RSUs will vest on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
December 31, 2020 Filed Jan 5, 2021 18:29 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	33,300	$0.00	$0.00	Disclosure SEC source: 0001209191-21-001575 · doc4.xml · derivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 33,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: 33.3% of the RSUs vested on each of December 31, 2018, December 31, 2019 and December 31, 2020, subject to the continuing service of the Reporting Person on each vesting date. F3 · derivative.expiration_date: 33.3% of the RSUs vested on each of December 31, 2018, December 31, 2019 and December 31, 2020, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
December 31, 2020 Filed Jan 5, 2021 18:29 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Tax withholdingClass B Common Stock	16,511	$1.30	$21,464.30	Disclosure SEC source: 0001209191-21-001575 · doc4.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,240,863 F1 · kind: Represents the number of shares of Class B Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the Reporting Person. Read SEC document
December 31, 2020 Filed Jan 5, 2021 18:29 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	33,300	$0.00	$0.00	Disclosure SEC source: 0001209191-21-001575 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,257,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 17, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	SaleClass B Common Stock	577,907	$1.14	$661,067.82	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 9 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,224,074 F3 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.13 to $1.17 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	689,656	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · derivative · entry 17 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 689,656 shares Expires 2021-08-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F13 · derivative.exercise_date: The RSU vested on August 17, 2020. The underlying vested shares settled on November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	186,000	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · derivative · entry 16 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 806,000 Underlying: Class B Common Stock · 186,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F12 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. F12 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	129,310	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · derivative · entry 15 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,139 Underlying: Class B Common Stock · 129,310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F11 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. F11 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	69,187	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · derivative · entry 14 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,563 Underlying: Class B Common Stock · 69,187 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F10 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. F10 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	37,500	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Class B Common Stock · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. F9 · derivative.expiration_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	37,500	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Class B Common Stock · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. F8 · derivative.expiration_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	9,375	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Underlying: Class B Common Stock · 9,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/4th of the RSUs vested on March 7, 2018, and the remainder will vest 1/20th quarterly in 12 equal installments and then 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. F7 · derivative.expiration_date: 1/4th of the RSUs vested on March 7, 2018, and the remainder will vest 1/20th quarterly in 12 equal installments and then 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. The underlying vested shares settled on November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	125,000	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 125,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 100% of the RSUs vested on May 16, 2020. The underlying vested shares settled on November 16, 2020. F6 · derivative.expiration_date: 100% of the RSUs vested on May 16, 2020. The underlying vested shares settled on November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	689,656	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 8 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,801,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on August 17, 2020. Delivery of the shares in settlement of the vested RSUs was deferred to November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	186,000	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 7 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,112,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	129,310	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 6 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 926,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	69,187	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 5 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 797,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	37,500	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	37,500	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	9,375	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020. Read SEC document
November 16, 2020 Filed Nov 18, 2020 17:03 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	125,000	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059168 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 16, 2020, these shares of Class B Common Stock were issued in settlement of the RSUs that vested on each of May 16, 2020, August 16, 2020 and November 16, 2020. Delivery of the shares in settlement of the RSUs that vested on May 16, 2020 and August 16, 2020 was deferred to November 16, 2020. Read SEC document
September 14, 2020 Filed Sep 16, 2020 17:05 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	GrantClass A Common Stock · Derivative	30,000	$0.00	$0.00	Disclosure SEC source: 0001209191-20-050725 · doc4.xml · derivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class B Common Stock · 30,000 shares Expires not disclosed F2 · derivative.exercise_price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F3 · derivative.exercise_price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F2 · derivative.exercise_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F3 · derivative.exercise_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F2 · derivative.expiration_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F3 · derivative.expiration_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document
September 14, 2020 Filed Sep 16, 2020 17:05 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	30,000	$0.00 Strike: $0.79	$0.00	Disclosure SEC source: 0001209191-20-050725 · doc4.xml · derivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 30,000 shares Expires 2020-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option has fully vested and is immediately exercisable. F2 · derivative.underlying: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F3 · derivative.underlying: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document
September 14, 2020 Filed Oct 20, 2020 19:20 UTC Amendment	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	ConversionClass A Common Stock · Derivative	30,000	$0.00	$0.00	Disclosure SEC source: 0001209191-20-055404 · doc4a.xml · derivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.exercise_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.expiration_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.expiration_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document
September 14, 2020 Filed Oct 20, 2020 19:20 UTC Amendment	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	ConversionClass B Common Stock	30,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-055404 · doc4a.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.